Live feed19:30:38·50dINSIDERFilingCSO & EVP, Head of Research Fitzgerald Kevin Joseph was granted 3,688 shares and sold $1,051,773 worth of shares (3,250 units at $323.62), increasing direct ownership by 2% to 21,860 units (SEC Form 4)ALNY· Alnylam Pharmaceuticals Inc.Health CareOriginal source